ScripThe end of each year brings a surge in venture capital funding announcements as biopharmaceutical companies and investors seek to close as many deals as possible before everyone takes off for the Dece
Pink SheetMerck & Co., Inc. is looking to see how the US Food and Drug Administration’s openness to using biomarkers in Alzheimer’s disease drug development may affect its programs. During its 29 July second q